Idorsia Insomnia Medication QUVIVIQ Now Covered by TRICARE
"This is a big win for patients suffering from insomnia," says Patty Torr, Idorsia US president and general manager, in a release.
Category: Prescription Drugs
Prescription Drugs
Latest
Prescription Drugs
Latest
Axsome Therapeutics to Acquire Sunosi from Jazz Pharmaceuticals
The acquisition of Sunosi adds a high-potential commercial asset to Axsome’s late-stage neuroscience portfolio.
Prescription Drugs
Latest
WAKIX Time-to-Onset & Cardiovascular Safety Data Presented at AAN 2021
"These analyses further characterize the efficacy and safety profile of WAKIX and its broad clinical utility for the treatment of excessive daytime sleepiness or cataplexy in adult patients with narcolepsy."
FDA Grants Orphan Drug Status to Xywav, Citing “Greatly Reduced Chronic Sodium Burden Compared to Xyrem”
The FDA also published its summary of clinical superiority findings for Xywav for the treatment of cataplexy or excessive daytime sleepiness associated with narcolepsy.
Read More
Purdue Pharma Studies Sleep Quality Outcomes of Methylphenidate HCl for ADHD
“As some adult patients with ADHD experience insomnia, there is considerable individual variability, and an identified need for more data on the effect of prescription ADHD stimulant medications on sleep.”
Read More
Two Poster Presentations Include New Post-Hoc Analyses That Highlight Clinical Effectiveness of WAKIX
“The analyses include both a traditional approach to presenting efficacy data, as well as one that underscores the clinical relevance of the findings, using [number needed to treat] and effect sizes to capture overall clinical benefit.”
Read MoreJazz Pharmaceuticals Shares Results from Sleep Medicine Research & Therapy Development
Thirteen abstracts sponsored by Jazz Pharmaceuticals and five abstracts from investigator-sponsored trials will be presented at SLEEP 2021.
Read More
Long-Term Use of Prescription Meds for Insomnia Not Linked to Better Quality Sleep
There was no difference in sleep quality or duration between those who did and didn’t take these meds for 1 to 2 years, the findings show.
Read MoreWAKIX Data Presented to Mental Health Professionals at APA Annual Meeting
Sleep disorders are highly comorbid with a multitude of psychiatric disorders and narcolepsy can have a significant impact on a person’s daily functioning, which may greatly affect their social, emotional and psychological well-being, and quality of life.
Read More
Jazz Pharmaceuticals Presents Phase 3 Results of Xywav in Idiopathic Hypersomnia
The AAN presentation further quantifies the previously reported Phase 3 top-line results.
Read More
What Region Is Most Associated with Fracture-Associated Prescription Drug Use?
Many commonly prescribed drugs—such as some sleep aids—are known to carry an increased risk of breaking a bone, by increasing falls, weakening bones, or both.
Read MoreTeva Raises Price for Nuvigil
Reuters: The hikes could help make up for lost revenue as doctors visits and new prescriptions plummeted during the global lockdown.
Read More
What We Know About Narcolepsy, Sodium Oxybate Use, Salt Intake & Cardiovascular Risk
A literature review from Stanford University looks at how the popular narcolepsy medication sodium oxybate impacts heart health.
Read More
Z-Drugs Have Similar or Greater Adverse Events in Dementia Patients as Benzos
Researchers studied the adverse events for 3,532 patients who had been prescribed Z-drugs and compared them to people with sleep disturbance who had not been prescribed sedatives and with patients who had been prescribed benzodiazepines.
Read MoreEuropean Commission Fines Teva & Cephalon for Delaying Entry of Generic Modafinil
The commission investigation has found that for several years, this “pay-for-delay” agreement eliminated Teva as a competitor and allowed Cephalon to continue charging high prices even if the main modafinil patent had long expired.
Read MoreFDA Approves HETLIOZ for Sleep Disturbances in Smith-Magenis Syndrome
Smith-Magenis Syndrome is a rare neurodevelopmental disorder, a defining feature of which is an “inverted” circadian rhythm.
Read More
Insomnia Patient Survey Offers Some Answers on Prescription Drug Use
Health Union, which creates condition-specific online patient communities, shared results from its Sleep Disorders In America survey.
Read More
Expanded WAKIX Label Could ‘Help Even More People Living with Narcolepsy’
The FDA says that Harmony Biosciences’ drug—previously approved for excessive daytime sleepiness in narcolepsy—works for cataplexy too. Harmony’s chief medical officer explains how this impacts healthcare practitioners and patients.
Read More